Baird Affirms Sarepta Therapeutics (SRPT) at 'Outperform'; Incrementally Positive on PTAB Decision (BMRN)
Go back to Baird Affirms Sarepta Therapeutics (SRPT) at 'Outperform'; Incrementally Positive on PTAB Decision (BMRN)| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 64.76 +0.13 (0.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.63 | 52 Week High | $108.96 | |||
| Open | $63.83 | 52 Week Low | $62.12 | |||
| Day High | $65.31 | P/E | N/A | |||
| Day Low | $63.64 | EPS | $-1.27 | |||
| Volume | 496,173 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 22.11 +1.17 (5.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.94 | 52 Week High | $63.73 | |||
| Open | $20.81 | 52 Week Low | $8.00 | |||
| Day High | $23.22 | P/E | N/A | |||
| Day Low | $20.63 | EPS | $-5.69 | |||
| Volume | 2,351,613 | |||||
